Selecxine
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination (NCT05525247) | Selecxine | 2022-12-21 |
Track Selecxine automatically
Every clearance here is in the API, with alerts when new ones post.